Old Drug Scaffold, New Activity: Thalidomide-Correlated Compounds Exert Different Effects on Breast Cancer Cell Growth and Progression-Reference-Cited by-同舟云学术

Old Drug Scaffold, New Activity: Thalidomide-Correlated Compounds Exert Different Effects on Breast Cancer Cell Growth and Progression

Published:2017-01-27 Issue:5 Volume:12 Page:381-389
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Iacopetta Domenico¹,Carocci Alessia²,Sinicropi Maria Stefania¹,Catalano Alessia²,Lentini Giovanni²,Ceramella Jessica¹,Curcio Rosita¹,Caroleo Maria Cristina¹

Affiliation:

1. Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; 87036 Arcavacata di Rende Italy

2. Department of Pharmacy-Drug Sciences; University of Bari “Aldo Moro”; 70126 Bari Italy

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference48 articles.

1. Thalidomide‐induced teratogenesis: History and mechanisms

2. Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease

3. Thalidomide: dermatological indications, mechanisms of action and side-effects

4. In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC);Journal of Nanoparticle Research;2024-05

2. Cell viability and cytotoxicity assays: Biochemical elements and cellular compartments;Cell Biochemistry and Function;2024-04

3. Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity;International Journal of Molecular Sciences;2024-02-23

4. Molecular targets and therapeutic strategies for triple-negative breast cancer;Molecular Biology Reports;2023-11-04

5. Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors;Archiv der Pharmazie;2023-07-14